Skip to main content

Table 2 Quantitative analysis of PROs in toxicity

From: Patients’ perspectives on palliative chemotherapy of colorectal and non - colorectal cancer: a prospective study in a chemotherapy- experienced population

Grade of PRO in toxicity Entity
  CRC Non-CRC u-GI NSCLC SCCHN
Stomatitis n= 57 n= 75 n=45 n=18 n=12
None 35.1% 61.3% 66.7% 66.7% 33.4%
Grade 1/2 54.4% 32.0% 31.1% 27.8% 41.6%
Grade 3/4 10.5% 6.7% 2.2% 5.5% 25.0%
Nausea n=54 n=70 n=44 n=14 n=12
None 44.4% 21.4% 18.2% 21.5% 33.4%
Grade 1/2 50.0% 68.6% 72.8% 71.4% 50.0%
Grade 3/4 5.6% 10.0% 9.0% 7.1% 16.6%
Emesis n=54 n=74 n=42 n=18 n=13
None 81.4% 75.7% 76.2% 72.3% 77.0%
Grade 1/2 16.7% 24.3% 23.8% 27.7% 23.0%
Grade 3/4 1.9% 0.0% 0.0% 0.0% 0.0%
Diarrhea n=56 n=74 n=44 n=17 n=13
None 35.7% 62.1% 54.6% 76.5% 69.3%
Grade 1/2 50.0% 33.8% 38.6% 23.5% 30.7%
Grade 3/4 14.3% 4.1% 6.8% 0.0% 0.0%
Fatigue n=57 n=76 n=45 n=18 n=13
None 7.0% 6.6% 6.7% 5.6% 7.7%
Grade 1/2 87.7% 81.6% 75.6% 94.4% 84.6%
Grade 3/4 5.3% 11.8% 17.7% 0.0% 7.7%
Sens . Neu . n=55 n=74 n=44 n=17 n=13
None 40.0% 36.5% 31.9% 41.2% 46.1%
Grade 1/2 65.4% 56.7% 59.1% 58.8% 46.1%
Grade 3/4 3.6% 6.8% 9.0% 0.0% 7.8%
Skin toxicity n=58 n=75 n=45 n=17 n=13
None 57.0% 64.0% 73.4% 64.8% 30.8%
Grade 1/2 27.5% 25.4% 24.4% 11.7% 46.1%
Grade 3/4 15.5% 10.6% 2.2% 23.5% 23.0%
Alopecia n=56 n=73 n=45 n=16 n=12
None 33.9% 24.6% 26.7% 18.75% 25.0%
Grade1 53.6% 56.2% 60.0% 50.0% 50.0%
Grade 2 12.5% 19.2% 13.3% 31.25% 25.0%
  1. Sens. Neu. = Sensory Neuropathy.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us